 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/04/2026 |
$25.26 |
$25.36 |
$24.88 |
$25.06 |
1.26M | | 02/05/2026 |
$25.22 |
$25.40 |
$23.86 |
$23.91 |
1.26M | | 02/06/2026 |
$24.27 |
$24.58 |
$23.73 |
$24.44 |
1.03M | | 02/09/2026 |
$24.45 |
$24.85 |
$24.20 |
$24.45 |
973.00K | | 02/10/2026 |
$24.53 |
$24.60 |
$24.03 |
$24.27 |
1.12M |
|
|
| Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class medicines for rare and difficult-to-treat diseases. Its flagship product, FIRDAPSE (amifampridine) tablets, is approved for treating Lambert-Eaton Myasthenic Syndrome (LEMS) in adults and children aged six to seventeen. The company also markets FYCOMPA (perampanel) CIII for treating focal onset seizures and primary generalized tonic-clonic seizures in people with epilepsy. Additionally, its portfolio includes AGAMREE (vamorolone), an oral suspension for treating Duchenne Muscular Dystrophy (DMD), which is a corticosteroid treatment for DMD patients. | |
|
Catalyst Pharmaceuticals (CPRX) has the following price history information. Looking back at CPRX historical stock prices for the last five trading days, on February 04, 2026, CPRX opened at $25.26, traded as high as $25.36 and as low as $24.88, and closed at $25.06. Trading volume was a total of 1.26M shares. On February 05, 2026, CPRX opened at $25.22, traded as high as $25.40 and as low as $23.86, and closed at $23.91. Trading volume was a total of 1.26M shares. On February 06, 2026, CPRX opened at $24.27, traded as high as $24.58 and as low as $23.73, and closed at $24.44. Trading volume was a total of 1.03M shares. On February 09, 2026, CPRX opened at $24.45, traded as high as $24.85 and as low as $24.20, and closed at $24.45. Trading volume was a total of 973.00K shares. On February 10, 2026, CPRX opened at $24.53, traded as high as $24.60 and as low as $24.03, and closed at $24.27. Trading volume was a total of 1.12M shares.
CPRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Catalyst Pharmaceuticals shares, starting with a $10,000 purchase of CPRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/12/2016 |
|
| End date: |
02/10/2026 |
|
| Start price/share: |
$1.76 |
|
| End price/share: |
$24.27 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
1,278.98% |
|
| Average Annual Total Return: |
29.99% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$137,851.51 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 02/04/2026 | $25.06 | | 02/05/2026 | $23.91 | | 02/06/2026 | $24.44 | | 02/09/2026 | $24.45 | | 02/10/2026 | $24.27 |
|
|
Free CPRX Email Alerts:
